Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2021-03-15 Sale | 2021-03-17 4:00 pm | Cue Biopharma Inc. | CUE | Pienta Kenneth Chief Medical Officer | 13,439 | $15.1 | $202,894 | 269,573 (Direct) | View |
2021-02-16 Sale | 2021-02-18 8:44 pm | Cue Biopharma Inc. | CUE | Pienta Kenneth Chief Medical Officer | 20,274 | $15.13 | $306,767 | 150,286 (Direct) | View |
2021-01-20 Sale(A) | 2021-02-18 8:40 pm | Cue Biopharma Inc. | CUE | Pienta Kenneth Chief Medical Officer | 2,720 | $15.07 | $40,980 | 19,280 (Direct) | View |
2021-01-20 Purchase | 2021-01-22 4:33 pm | Cue Biopharma Inc. | CUE | Pienta Kenneth Chief Medical Officer | 2,720 | $15.07 | $40,980 | 4,720 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2022-03-25 Option Award | 2022-03-29 4:12 pm | N/A 2032-03-24 | Cue Biopharma Inc. | CUE | Pienta Kenneth Chief Medical Officer | 40,000 | $0 | 40,000 (Direct) | View |
2021-12-20 Option Award | 2021-12-21 4:05 pm | N/A 2031-12-20 | Cue Biopharma Inc. | CUE | Pienta Kenneth Chief Medical Officer | 80,000 | $0 | 80,000 (Direct) | View |
2021-03-15 Exercise | 2021-03-17 4:00 pm | N/A N/A | Cue Biopharma Inc. | CUE | Pienta Kenneth Chief Medical Officer | 13,439 | $5 | 269,573 (Direct) | View |
2021-03-15 Exercise | 2021-03-17 4:00 pm | N/A 2024-04-17 | Cue Biopharma Inc. | CUE | Pienta Kenneth Chief Medical Officer | 13,439 | $0 | 269,573 (Direct) | View |
2021-02-17 Exercise | 2021-02-18 8:44 pm | N/A N/A | Cue Biopharma Inc. | CUE | Pienta Kenneth Chief Medical Officer | 2,994 | $5 | 150,286 (Direct) | View |
2021-02-16 Exercise | 2021-02-18 8:44 pm | N/A 2023-11-16 | Cue Biopharma Inc. | CUE | Pienta Kenneth Chief Medical Officer | 20,274 | $0 | 150,286 (Direct) | View |
2021-02-16 Exercise | 2021-02-18 8:44 pm | N/A N/A | Cue Biopharma Inc. | CUE | Pienta Kenneth Chief Medical Officer | 17,280 | $2.86 | 150,286 (Direct) | View |
2021-01-20 Exercise(A) | 2021-02-18 8:40 pm | N/A 2023-11-16 | Cue Biopharma Inc. | CUE | Pienta Kenneth Chief Medical Officer | 2,720 | $0 | 19,280 (Direct) | View |
2021-01-20 Exercise(A) | 2021-02-18 8:40 pm | N/A N/A | Cue Biopharma Inc. | CUE | Pienta Kenneth Chief Medical Officer | 2,720 | $2.86 | 19,280 (Direct) | View |
2021-02-10 Option Award | 2021-02-12 5:52 pm | N/A 2031-02-09 | Cue Biopharma Inc. | CUE | Pienta Kenneth Chief Medical Officer | 50,000 | $0 | 50,000 (Direct) | View |
2020-03-24 Option Award | 2020-03-26 4:11 pm | N/A 2030-03-24 | Cue Biopharma Inc. | CUE | Pienta Kenneth Chief Medical Officer | 100,000 | $0 | 100,000 (Direct) | View |